Published April 15, 2019
| Version v1
Conference paper
Open
Dysregulation of mutant ALK2: More than just loss of binding of inhibitory factors
Description
Poster presented at the Biochemical Society Conference: BMP Signalling in Cancer II held at St. Annes college in Oxford, April 2019. You can read more about it here on the SGC open notebook.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
2019_biochemicalsociety_poster.pdf
Files
(5.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:e2029f487b892d3540d153b12b9468ea
|
5.3 MB | Preview Download |